Nuvectis Pharma Inc

NASDAQ:NVCT   3:58:49 PM EDT
8.79
-0.22 (-2.44%)
Earnings Announcements

Nuvectis Pharma Inc Reports Q2 Loss Per Share Of $0.28

Published: 08/05/2022 12:44 GMT
Nuvectis Pharma Inc (NVCT) - Nuvectis Pharma, Inc. Reports Second Quarter 2022 Financial Results and Business Highlights.
Nuvectis Pharma Inc - Qtrly Loss per Share $0.28.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.27

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.27

More details on our Analysts Page.